Epithelial cells are held together and connected by several different types of structures that form cell-cell contacts. One of these structures, found near the top surface of the cell, is the adherens junction. This junction is critical for organ development, tissue architecture and cell function; disruption of adherens junctions can lead to inflammatory bowel disease, disorders of the skin and hair, and certain types of cancer.
Researchers at the Medical University of South Carolina (MUSC) who study adherens junctions have identified the RNA interference (RNAi) machinery, a biological process that regulates gene expression, as a critical interacting complex that influences epithelial cell biology. Their results, published on Apr. 7 in the International Journal of Molecular Sciences , showed that the RNAi machinery is predominantly localized at adherens junctions in normal colon epithelial cells but is mis-localized in colon cancer.
"This goes against the dogma in the field that the core components of the RNAi machinery localize either in the nucleus or the cytoplasm. When you look at tissues, it is so dominant at the apical junctions and a very strong feature of the colonic epithelium," said Antonis Kourtidis, Ph.D., an assistant professor in the department of Regenerative Medicine and Cell Biology and associate member of Hollings Cancer Center, who studies adherens junctions in cell behavior and disease.
The Kourtidis Lab focuses on the intersection of cell-cell interactions and RNA biology. Previous work from Dr. Kourtidis has shown that in Caco2 cells (a human intestinal epithelial cell line), the adherens junction protein PLEKHA7 (pleckstrin homology domain containing A7) recruits numerous RNA-binding proteins including members of the core RNAi machinery. At the adherens junction, the RNAi machinery regulated the processing and function of tumor suppressing microRNAs (miRNAs). Importantly, when PLEKHA7 was depleted, the RNAi machinery was mis-localized, several of these miRNAs were dysregulated, and the cells became more tumorigenic.
The Kourtidis Lab decided to build on these past findings in this current paper. "How physiologically relevant is this to either normal tissues or to disease," asked Kourtidis. "In this paper, we wanted to see what holds true for the colonic epithelium."
Examination of primary colonic epithelial cells and of normal colon tissues confirmed that the RNAi machinery co-localized with PLEKHA7 at adherens junctions; however, both PLEKHA7 and the RNAi machinery were mis-localized in human tumor samples at all stages of disease. Junctional localization of PLEKHA7 and the RNAi machinery was also lost in several human colon cancer cell lines. Interestingly, it was noted that PLEKHA7 in these cell lines was mis-localized due to increased activity of the human kinase Src, a well characterized proto-oncogene and promoter of colon cancer. Pharmacological inhibition of Src restored junctional localization of PLEKHA7 and the RNAi machinery in one of the human colon cancer cell lines, hinting at a potential mechanism of regulation. Related Stories
Also in Industry News
How to decide whether or not to start treatment for prostate cancer?
Analysis of the SARS-CoV-2 proteome via visual tools
$65m investment increases British Patient Capital’s exposure to life sciences and health technology